Roka Bioscience Q1 Revenues Grow 7 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Roka Bioscience said after the close of the market Wednesday that its first quarter revenues rose 7 percent.

For the three months ended March 31, the Warren, New Jersey-based food safety testing firm reported revenues of $1.6 million compared to $1.5 million in the year-ago period. The revenue spike was due to an increase in the number of Atlas molecular testing platforms placed with commercial customers and increased use of the instruments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.